Release Date: April 25, 2024
Expiration Date: October 18, 2025
Activity Overview
This online activity is designed to update clinicians on data presented at meetings including Hawaiian Eye and Retina, held January 13-19, 2024 in Wailea, Hawaii, and Angiogenesis, Exudation, and Degeneration, held virtually on February 3, 2024. Expert thought leaders provide insights to help clinicians apply these findings to their management of patients with nAMD and DME when using newer therapies that support longer treatment intervals.
Target Audience
This educational activity is directed toward retina specialists, general ophthalmologists, and general optometrists.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize emerging evidence regarding the management of retinal diseases as presented at major medical conferences in 2024
- Identify appropriate patient populations who may benefit from evidence-based therapies used in the management of nAMD based on clinical presentation and goals of treatment
- Identify appropriate patient populations who may benefit from evidence-based therapies used in the management of DME based on clinical presentation and goals of treatment
- Integrate evidence regarding advanced dosing strategies into individualized management plans for patients with DME
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
